Cervical Cancer Diagnostic Tests Market

Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, Endocervical Curettage Test, and HPV Test), By Age Group (Age 20–40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


Cervical cancer, or cancer of the cervix, begins on the surface of your cervix. It happens when the cells on your cervix begin to change to precancerous cells. There are two main types of cancer of the cervix: squamous cell carcinomas and adenocarcinomas. About 80% to 90% of cervical cancers are squamous cell carcinomas, while 10% to 20% are adenocarcinomas. Watery or bloody vaginal discharge that may be heavy and can have a foul odor, vaginal bleeding after intercourse, between menstrual periods or after menopause and menstrual periods may be heavier and last longer than normal are some sign and symptoms of stage 1 cervical cancer. Most cervical cancers are caused by the virus HPV, a sexually transmitted infection. Human papillomavirus (HPV) spreads through sexual contact (anal, oral or vaginal) and can lead to cancer. Most people will get HPV at some point in their lives and not realize it because their bodies fight the infection. Receiving regular gynecological exams, getting Pap tests and practicing safe sex are the most important steps that you can take toward the prevention of cervical cancer. Surgery, radiation and chemotherapy are the main treatments for cervical cancer. Pap smear, colposcopy, and endocervical curettage (ECC) procedures are performed for the diagnosis of cervical cancer. Increasing awareness regarding cervical cancer in emerging economies and increasing funding for research and development in diagnosis of cervical cancer are expected to drive growth of the market during the forecast period.

Market Dynamics

Over the projected period, the global market for cervical cancer diagnostic tests is anticipated to increase due to the rising incidence of the disease, the high frequency of patients infected with the human papillomavirus (HPV), and the rising number of teenage sex experiences. For instance, in February 2022, according to the World Health Organization (WHO), Cervical cancer is the fourth most common cancer among women globally, with an estimated 604 000 new cases and 342 000 deaths in 2020. About 90% of the new cases and deaths worldwide in 2020 occurred in low- and middle-income countries such as Afghanistan, Bangladesh, India, China, etc.

Key features of the study:
  • This report provides in-depth analysis of the global cervical cancer diagnostic tests market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cervical cancer diagnostic tests market based on the following parameters–company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study are Guided Therapeutics, Inc., Abbott, Beckman Coulter, Inc., BD (Becton, Dickinson and Company), F. Hoffmann-La Roche Ltd, Bio Farma, Hologic, Inc., Oncgnostics GmbH, AstraZeneca, MobileODT, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., DYSIS Medical Inc., The Cooper Companies Inc., Danaher, Quest Diagnostics, Arbor Vita Corporation, and Zilico.
  • Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global cervical cancer diagnostic tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cervical cancer diagnostic tests market
Detailed Segmentation:
  • Global Cervical Cancer Diagnostic Tests Market, By Test Type:
  • Pap Smear Test
  • Colposcopy Test
  • Endocervical curettage Test
  • HPV Test
  • Global Cervical Cancer Diagnostic Tests Market, By Age Group:
  • Age 20-40
  • Age above 40
  • Global Cervical Cancer Diagnostic Tests Market, By Region:
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Guided Therapeutics, Inc
  • Abbott
  • Beckman Coulter, Inc.
  • BD (Becton, Dickinson and Company)
  • Hoffmann-La Roche Ltd
  • Bio Farma
  • FinVector Vision Therapies
  • Hologic, Inc.
  • Oncgnostics GmbH
  • AstraZeneca
  • MobileODT
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • DYSIS Medical Inc.
  • The Cooper Companies Inc.
  • Danaher
  • Quest Diagnostics
  • Arbor Vita Corporation
  • Zilico


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Test Type
Market Snapshot, By Age Group
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Attractiveness Analysis
Market Opportunities
Merger, Acquisition, Collaborations
Funding and Investment
Regulatory Guideline and Compliances
Epidemiology
Pricing Analysis
Key Developments
PEST Analysis
PORTER’s Analysis
4. Global Cervical Cancer Diagnostic Tests Market– COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Cervical Cancer Diagnostic Tests Market, By Test Type, 2018-2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Pap Smear Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Colposcopy Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Endocervical curettage Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
HPV Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
6. Global Cervical Cancer Diagnostic Tests Market, By Age Group, 2018-2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segments Trends
Age 20-40
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Age above 40
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
7. Global Cervical Cancer Diagnostic Tests Market, By Region, 2018-2030, (US$ Billion)
Introduction
Market Share Analysis, By Region, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Region, 2018–2030
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Billion)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Guided Therapeutics, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Abbott
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Beckman Coulter, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
BD (Becton, Dickinson and Company)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Hoffmann-La Roche Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Bio Farma
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Hologic, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Oncgnostics GmbH
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
AstraZeneca
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
MobileODT
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Agilent Technologies, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Thermo Fisher Scientific Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
DYSIS Medical Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
The Cooper Companies Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Danaher
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Quest Diagnostics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Arbor Vita Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Zilico
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
9. Section
Research Methodology
About Us
*Browse 34 market data tables and 26 figures on “Cervical Cancer Diagnostic Tests Market”- Global forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings